<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03029676</url>
  </required_header>
  <id_info>
    <org_study_id>U/1/2017</org_study_id>
    <nct_id>NCT03029676</nct_id>
  </id_info>
  <brief_title>The Assessment of POCD After TURBT Under Spinal Anesthesia</brief_title>
  <official_title>The Assessment of Postoperative Cognitive Dysfunction After Transurethral Resection of Bladder Tumor Under Spinal Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Warsaw</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Warsaw</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the influence of premedication on cognitive functions in patients&#xD;
      undergoing transurethral resection of bladder tumor under spinal anesthesia. The aims of&#xD;
      premedication are anxiolysis, analgesia and the reduction of perioperative risk among the&#xD;
      patients with comorbidities. The patients will be randomly allocated to receive premedication&#xD;
      either with opioid solely or with benzodiazepine combined with opioid. The anesthetic&#xD;
      technique is standardized.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Trans-urethral resection of bladder tumor (TURBT) is the basic endoscopic procedure for&#xD;
      management of bladder cancer and if there are no contraindications, it is performed under&#xD;
      spinal anesthesia. The condition usually occurs among elderly patients, every 9 of 10 is&#xD;
      older than 55 years. At this age the postoperative cognitive dysfunction (POCD) is a common&#xD;
      complication as the risk increases with age. There are some studies indicating that using&#xD;
      benzodiazepines during the perioperative period can also increase the number of registered&#xD;
      POCD in patients undergoing anesthesia. Postoperative cognitive dysfunction (POCD) occurs&#xD;
      after operations under regional and general anesthesia as well. The study was planed to&#xD;
      evaluate the risk of POCD among urological patients and to asses whether combining&#xD;
      benzodiazepines with opioids for premedication increases this risk.&#xD;
&#xD;
      The participants after giving the informed consent can participate in the study. The Beck&#xD;
      Depression Inventory is performed to rule out the patients with depression. The cognitive&#xD;
      functions are tested with Montreal Cognitive Assessment before the surgery and subsequently&#xD;
      in the first 24 hours after surgery, three weeks later (while patients come back to receive&#xD;
      histopathological examination), and finally six months after surgery (during control&#xD;
      cystoscopy).&#xD;
&#xD;
      During anesthesia, the patients will be randomly allocated to receive premedication either&#xD;
      with opioid solely or with benzodiazepine combined with opioid. The anesthetic technique is&#xD;
      standardized. If the premedication is needed before the surgery the hydroxyzine will be&#xD;
      administrated.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Anticipated">June 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>the participant is not performed about the type of premedication performed</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative cognitive disfunction</measure>
    <time_frame>6 months</time_frame>
    <description>evaluated by Montreal Cognitive Assesment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the influence of benzodiazepines on POCD</measure>
    <time_frame>6 months</time_frame>
    <description>evaluated by Montreal Cognitive Assesment</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Bladder Tumor</condition>
  <condition>Postoperative Cognitive Dysfunction</condition>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>spinal anesthesia premedication with benzodiazepine and opioid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group K</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>spinal anesthesia premedication with opioid</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>benzodiazepines</intervention_name>
    <description>sedative</description>
    <arm_group_label>Group B</arm_group_label>
    <other_name>midazolam</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>opioid</intervention_name>
    <description>analgetic, sedative</description>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_label>Group K</arm_group_label>
    <other_name>fentanyl</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>spinal anesthesia</intervention_name>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_label>Group K</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  informed consent&#xD;
&#xD;
          -  transurethral resection of the bladder tumor&#xD;
&#xD;
          -  spinal anesthesia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients' refusal&#xD;
&#xD;
          -  contraindications for spinal anesthesia&#xD;
&#xD;
          -  skin lesions at injection site&#xD;
&#xD;
          -  depression&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>I Department of Anaesthesiology and Intensive Care, Medical University of Warsaw</name>
      <address>
        <city>Warsaw</city>
        <zip>02-005</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karolina Dobronska, MD</last_name>
      <phone>+48 22 501 17 27</phone>
      <email>karolinapladzyk@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Lidia I Jureczko, PhD MD</last_name>
      <phone>+48 22 501 17 27</phone>
      <email>jureczko@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Karolina Dobronska, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lidia I Jureczko, PhD MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <study_first_submitted>January 20, 2017</study_first_submitted>
  <study_first_submitted_qc>January 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 24, 2017</study_first_posted>
  <last_update_submitted>January 20, 2017</last_update_submitted>
  <last_update_submitted_qc>January 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Warsaw</investigator_affiliation>
    <investigator_full_name>Karolina Dobro≈Ñska</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>spinal anesthesia, TURBT, POCD, premedication</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Bladder Neoplasms</mesh_term>
    <mesh_term>Postoperative Cognitive Complications</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Midazolam</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

